Summit Therapeutics Inc. SMMT
Regular-session close
After hours · Nov 20, 7:42 PM ET
- YTD
- -43.11%
- 1 year
- -39.51%
Held by funds
107 US ETFs and mutual funds hold SMMT · largest positions
- VTI 0.00% of fund $65.57M
- VB 0.03% of fund $57.34M
- XBI 0.41% of fund $39.38M
- VBR 0.06% of fund $37.27M
- FGCKX 0.04% of fund $34.63M
- VXF 0.03% of fund $29.02M
- FBIOX 0.28% of fund $16.95M
- FSPHX 0.19% of fund $12.68M
- IBB 0.12% of fund $12.55M
- FSMAX 0.03% of fund $12.47M
- NIW 0.06% of fund $11.65M
- FSMDX 0.02% of fund $9.30M
- FNCMX 0.03% of fund $8.26M
- IWP 0.05% of fund $8.24M
- NBF 0.01% of fund $7.15M
- NIZ 0.01% of fund $6.98M
- PINK 2.13% of fund $6.57M
- VHT 0.03% of fund $6.49M
- IWR 0.01% of fund $6.24M
- FHCIX 0.18% of fund $6.09M
Ownership
- Institutions 17.5%
- Insiders 80.8%
- Public and other holders 1.75%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baker Bros. Advisors, LP | 4.10% | 32,786,348 | 326.22M | Sep 29, 2026 |
| Blackrock Inc. | 1.30% | 10,363,750 | 103.12M | Sep 29, 2026 |
| FMR, LLC | 1.02% | 8,136,745 | 80.96M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 0.90% | 7,230,441 | 71.94M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 0.84% | 6,717,642 | 66.84M | Sep 29, 2026 |
| State Street Corporation | 0.76% | 6,093,474 | 60.63M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.46% | 3,707,548 | 36.89M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 0.45% | 3,635,145 | 36.17M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 0.33% | 2,667,317 | 26.54M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.32% | 2,531,231 | 25.19M | Jun 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 0.26% | 2,047,862 | 20.38M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.22% | 1,778,361 | 17.69M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs SMMT, and what each was last paid
Mahkam Zanganeh, Co-CEO, President & DirectorAverage age 62
| Name | Title | Pay | Age |
|---|---|---|---|
| Mahkam Zanganeh | Co-CEO, President & Director | £1.03M | 56 |
| Robert W. Duggan | Co-CEO & Executive Chairman | £172K | 82 |
| Manmeet Singh Soni | Chief Operating Officer, Chief Financial Officer & Director | £1.03M | 48 |
| Allen S. Yang | Chief R&D Strategy Officer | — | 58 |
| Elaine Carla Stracker | Chief Legal Officer | — | 65 |
| Urte Gayko | Chief Regulatory, Quality & Pharmacovigilance Officer | — | 55 |
| Bhaskar Anand | Chief Accounting Officer & Head of Finance | — | 48 |
| Dave Gancarz | Chief Business & Strategy Officer | — | — |
| Nathan LiaBraaten | Senior Director of Investor Relations | — | — |
| Robert LaCaze | Chief Commercial Officer | — | — |
| Kay Elizabeth Davies | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor | — | 75 |
| Wang Clow Fong | Chief Biometrics Officer | — | 68 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANAND BHASKAR | Officer | Stock Award(Grant) | Oct 7, 2026 | 261,047 |
| DUGGAN ROBERT WILLIAM | Chief Executive Officer | Conversion of Exercise of derivative security | Nov 15, 2026 | 0 |
| SONI MANMEET SINGH | Chief Operating Officer | Conversion of Exercise of derivative security | Nov 15, 2026 | 3,224,380 |
| XIA YU | Director | Purchase | Oct 20, 2025 | 0 |
| ZANGANEH MAHKAM | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security | Nov 15, 2026 | 610,516,000 |
